Malvern, PA, United States of America

Tuula Ryde

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 295(Granted Patents)


Company Filing History:


Years Active: 2002-2020

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Tuula Ryde: Innovator in Nanoparticulate Formulations

Introduction

Tuula Ryde is a prominent inventor based in Malvern, PA (US), known for her significant contributions to the field of pharmaceutical formulations. With a remarkable portfolio of 15 patents, she has made strides in developing innovative solutions that enhance drug delivery and efficacy.

Latest Patents

Among her latest inventions are nanoparticulate meloxicam formulations. These formulations are directed towards creating nanoparticulate compositions comprising meloxicam particles with an effective average particle size of less than about 2000 nm. This advancement holds potential for improving the therapeutic effects of meloxicam, a nonsteroidal anti-inflammatory drug.

Career Highlights

Throughout her career, Tuula has worked with notable companies such as Elan Pharma International Limited and Alkermes Pharma Ireland Limited. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations and contribute to the development of cutting-edge drug formulations.

Collaborations

Tuula has collaborated with esteemed professionals in her field, including John Dallas Pruitt and Eugene Rex Cooper. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Tuula Ryde's work in nanoparticulate formulations exemplifies her dedication to innovation in the pharmaceutical industry. Her contributions continue to pave the way for advancements in drug delivery systems, ultimately benefiting patients and healthcare providers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…